Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study

Affiliations

• ¹ Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
• ² Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA.
• ³ Division of Hematology and Medical Oncology,Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
• ⁴ Division of Hematology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
• ⁵ Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Winship Cancer Institute of Emory University, Atlanta, GA.
• ⁶ Department of Haematology, Plymouth University Medical School, Plymouth.
• ⁷ AstraZeneca, South San Francisco, CA.
• ⁸ AstraZeneca, Gaithersburg, MD.
• ⁹ Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester. [email protected].